CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 50 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 2.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62,641,362 | +4.5% | 9,681,818 | 0.0% | 0.97% | +2.3% |
| Q2 2023 | $59,930,453 | +60.8% | 9,681,818 | 0.0% | 0.94% | +118.2% |
| Q1 2023 | $37,274,999 | +24.2% | 9,681,818 | 0.0% | 0.43% | +9.1% |
| Q4 2022 | $30,013,636 | -22.9% | 9,681,818 | 0.0% | 0.40% | -13.3% |
| Q3 2022 | $38,921,000 | -17.5% | 9,681,818 | 0.0% | 0.46% | -25.6% |
| Q2 2022 | $47,150,000 | -45.7% | 9,681,818 | 0.0% | 0.62% | -22.4% |
| Q1 2022 | $86,846,000 | -20.3% | 9,681,818 | 0.0% | 0.79% | -5.6% |
| Q4 2021 | $109,017,000 | -32.6% | 9,681,818 | 0.0% | 0.84% | -11.2% |
| Q3 2021 | $161,686,000 | +385.3% | 9,681,818 | +545.5% | 0.95% | +301.3% |
| Q2 2021 | $33,315,000 | – | 1,500,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Index Venture Life Associates VI Ltd | 9,961,789 | $112,170,000 | 100.00% |
| Medicxi Ventures Management (Jersey) Ltd | 18,123,892 | $204,075,000 | 51.07% |
| Vida Ventures Advisors, LLC | 3,931,818 | $44,272,000 | 16.56% |
| OUP Management Co., LLC | 2,341,891 | $26,370,000 | 11.89% |
| Samsara BioCapital, LLC | 1,459,693 | $16,436,000 | 3.19% |
| VR Adviser, LLC | 1,127,272 | $12,693,000 | 1.74% |
| Affinity Asset Advisors, LLC | 419,144 | $4,720,000 | 1.71% |
| Cormorant Asset Management, LP | 2,489,894 | $28,036,000 | 1.67% |
| Kynam Capital Management, LP | 239,041 | $2,692,000 | 1.44% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $109,017,000 | 0.84% |